 |
|
Infliximab (Anti–Tumor Necrosis Factor  Antibody)
A Novel, Highly Effective Treatment of Recalcitrant Subcorneal Pustular Dermatosis (Sneddon-Wilkinson Disease)
Constanze Voigtländer, MD;
Matthias Lüftl, MD;
Gerold Schuler, MD;
Michael Hertl, MD
From the Department of Dermatology, University of Erlangen-Nürnberg, Erlangen, Germany.
Arch Dermatol. 2001;137:1571-1574.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
REPORT OF A CASE
A 79-year old woman presented with a 7-year history of subcorneal pustular dermatosis (SPD). Primary lesions presented as widespread symmetrical eruptions with erythema and flaccid pustules of up to 5 mm in diameter (Figure 1A). Diagnosis was based on the clinical symptoms and the characteristic histologic finding of subcorneal sterile pustules in several skin biopsy specimens (Figure 2A). The results of indirect and direct immunofluorescence analyses were negative (not shown). The clinical course was resistant to multiple therapeutic trials including colchicine, retinoids, systemic glucocorticosteroids, UV phototherapy, azathioprine, and azulfidine. Dapsone treatment had to be discontinued because the patient developed hemolytic anemia. A year prior to presenting to our department, the patient was diagnosed with breast cancer and underwent ablative surgery with dissection of the regional axillary lymph nodes. At the time of admission to . . . [Full Text of this Article]
THERAPEUTIC CHALLENGE
SOLUTION
COMMENT
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The case of SLE associated Sneddon-Wilkinson pustular disease successfully and safely treated with infliximab
Naretto et al.
Lupus 2009;18:856-857.
Addition of Low-Dose Methotrexate to Infliximab in the Treatment of a Patient With Severe, Recalcitrant Pustular Psoriasis
Barland and Kerdel
Arch Dermatol 2003;139:949-950.
FULL TEXT
|
